David Glenn 4

What Happened
David Glenn, Chief Financial Officer of Phibro Animal Health Corp (PAHC), had 30,000 restricted stock units (RSUs) settle into shares on Feb 9, 2026. To satisfy tax withholding required on the RSU vesting, 12,528 of those shares were sold in a broker-assisted cashless transaction on Feb 11, 2026 for a total of approximately $646,758 (weighted avg price $51.63).

Key Details

• Transaction dates: RSU settlement reported 2026-02-09; shares sold to cover taxes 2026-02-11 (filed 2026-02-11). Filing appears timely (within the 2-business-day window).
• Shares issued on settlement: 30,000 RSUs settled into 30,000 shares (footnote: RSUs = contingent right to one share).
• Shares sold for tax withholding: 12,528 shares disposed at a weighted average price of $51.63 (price range $51.54–$52.03).
• Net implied shares retained from this vesting event: 17,472 shares (30,000 issued − 12,528 sold), as implied by the filing.
• Footnotes: F2 confirms the sale was to satisfy tax withholding; F3 notes the reported sale price is a weighted average; F4/F5 summarize the original 300,000-RSU grant (150,000 time-vesting, 150,000 performance-vesting with a 5-year performance measure).
• Shares owned after transaction: not explicitly stated in the provided filing extract.

Context
This reporting reflects routine RSU settlement and a sale strictly to cover tax obligations (broker-assisted cashless exercise), not an open-market investment decision. For derivative/RSU items, the filing shows the conversion of RSUs to shares and the subsequent withholding sale; refer to the footnotes for grant and vesting details.